Skip to main content
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial
Plasma Neurofilament Analysis in VITALITY-ALS
Fast Skeletal Muscle Troponin Activator CK-4015089 Improves Muscle Function in a FSHD Mouse Model with Muscle Weakness
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
Relationship between quantitative strength and functional outcomes in the phase 2 FORTITUDE-ALS trial
Fast Skeletal Muscle Troponin Activator CK-4015089 Improves Muscle Function in a FSHD Mouse Model with Muscle Weakness
Tirasemtiv Enhances Submaximal Muscle Tension in an Acta1:p.Asp286Gly Mouse Model of Nemaline Myopathy
Feasibility Assessment of Using the MiToS Staging System for Conducting Economic Evaluation in Amyotrophic Lateral Sclerosis
Time From Amyotrophic Lateral Sclerosis Symptom Onset to Key Disease Milestones: Analysis of Data From a Multinational Cross-Sectional Survey
Site and Participant Perspectives on Participating in an ALS Trial Designed to Reduce Burden: COURAGE-ALS